APAM vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
APAM exhibits strong financial health with a Piotroski F-Score of 7/9, indicating solid operational performance and balance sheet strength. The company trades at a significant premium to its Graham Number ($21.82) and intrinsic value estimate ($25.97), though its low P/E of 11.61 relative to sector average (21.34) suggests value appeal. However, declining earnings growth (YoY: -9.40%) and bearish insider activity offset strong profitability metrics like 49.58% ROE and 33.79% operating margin. Analysts hold a consensus 'hold' rating with a near-current target price of $43.25, aligning with muted expectations.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
APAM vs JPM: Head-to-Head Comparison
This page compares Artisan Partners Asset Management Inc. (APAM) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.